ARUP Laboratories Launches National Disease Trends Dashboard
SALT LAKE CITY, May 13, 2026 ARUP Laboratories has launched the first U.S. National Infectious Disease Test Positivity Trends...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
SALT LAKE CITY, May 13, 2026 ARUP Laboratories has launched the first U.S. National Infectious Disease Test Positivity Trends...
SECAUCUS, N.J., March 2, 2026 Quest Diagnostics (NYSE: DGX) has introduced Quest AI Companion, an AI-powered chat feature integrated...
AliveDx, a global in-vitro diagnostics innovator, today announced it has submitted a 510(k) premarket notification to the U.S. Food...
